Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

21 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Recruiting

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

NCT05463263

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Memorial Sloan Kettering New York, United States
  • Hôpital Saint-Louis Paris, France
View all 15 locations
View Trial Details
Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

NCT06561048

Conditions
Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma, Hemic and Lymphatic Diseases, +16 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, Irvine Irvine, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View all 34 locations
View Trial Details
Recruiting

MB-105 in Patients With CD5 Positive T-cell Lymphoma

NCT06534060

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of San Diego (UCSD)-Moores Cancer Center San Diego, California, United States
  • SCRI - Colorado Blood Cancer Institute (CBCI) Denver, Colorado, United States
  • Moffitt Cancer Center Magnolia Campus Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Recruiting

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

NCT05476770

Conditions
ALL, AML, Acute Undifferentiated Leukemia, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • Children's Hospital Colorado Denver, Colorado, United States
View all 31 locations
View Trial Details
Completed

Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma

NCT03703375

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Local Institution - 41822 Sapporo, Hokkaido, Japan
  • Local Institution - 41922 Okayama, Okayama-ken, Japan
  • Local Institution - 41722 Sayama, Osaka, Japan
  • Local Institution - 41422 Hidaka, Saitama-Pref, Japan
View Trial Details

Related conditions